Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
npj Biofilms and Microbiomes: Gut-Lung Regulatory Pathway—Cloud-Clone Spermidine ELISA Kit Empowers Mechanistic Research
EIN Presswire
Probiotic-derived cinnamic acid drives anti-asthma effects independent of resident gut microbiota HUSTON, TX, UNITED STATES, September 10, 2026 /EINPresswire.com/ -- Allergic asthma remains a major clinical challenge with limited curative...
D’Art Deploys a New Retail Identity for Berger Paints Across India
EIN Presswire
D’Art collaborated with Berger Paints for its PAN-India retail transformation, creating immersive, consistent stores that strengthen visibility and engagement.
NANOBIOTIX to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire, Inc.
PARIS and CAMBRIDGE, Mass., Sept. 09, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “Company”), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for...
Actuate to Present at the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire, Inc.
CHICAGO and FORT WORTH, Texas, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of high-impact,...
Department of Commerce Announces Finalization of CHIPS R&D Award with GlobalFoundries
National Institute of Standards and Technology
WASHINGTON, D.C. — The U.S. Department of Commerce announced the signing of a final award of up to $375 million to GlobalFoundries under the CHIPS and Science Act. This award provides funding towards R&D to support the establishment of a secure,...
Kane Biotech to Host Commercial Update Webcast on September 16
GlobeNewswire, Inc.
WINNIPEG, Manitoba, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”), a biotechnology company commercializing and developing technologies and products that address microbial biofilms, today...
Four Biotech Stories Heating Up Right Now
GlobeNewswire, Inc.
DENVER, Sept. 09, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) -- Across different corners of the market, the latest developments are putting investors’ attention back on tangible catalysts: NeOnc Technologies Holdings (NASDAQ:NTHI) is pairing...
CivilGEO Leads the Way in G2 Fall 2026 with 36 Badges for Civil Engineering Design
EIN Presswire
MADISON, WI, UNITED STATES, September 9, 2026 /EINPresswire.com/ -- CivilGEO, a leading provider of civil engineering design software, today announced 36 badges in G2’s Fall 2026 Grid® Reports and Index rankings.
Opus Genetics Announces Positive Low Dose Cohort 1 Data from Phase 1/2 Clinical Trial of OPGx-BEST1 and Successful FDA Type C Meeting with Potential Phase 3 Dosing in 2027
GlobeNewswire, Inc.
OPGx-BEST1 demonstrated a favorable safety and tolerability profile with no serious adverse events or dose-limiting toxicities observed All five participants demonstrated clinically meaningful improvement in visual function, with structural...
Department of Commerce Announces Finalization of CHIPS R&D Award with PsiQuantum
National Institute of Standards and Technology
WASHINGTON, D.C. — The U.S. Department of Commerce announced today the signing of a final award of up to $100 million to PsiQuantum under the CHIPS and Science Act. The R&D funded by this award addresses key photonic quantum computing technical...
RareGen to Mark Five Years of Advocacy at Annual Membership Summit in Washington, D.C.
EIN Presswire
Fifth annual gathering will highlight RareGen’s growth in rare disease policy, disability rights, health equity, and international advocacy WASHINGTON D.C., VA, UNITED STATES, August 31, 2026 /EINPresswire.com/ -- RareGen will host its 5th...
Department of Commerce Announces Finalization of CHIPS R&D Award with D-Wave
National Institute of Standards and Technology
WASHINGTON, D.C. — The U.S. Department of Commerce announced today the signing of a final award of up to $100 million to D-Wave under the CHIPS and Science Act. This award will fund R&D for the critical advancement of semiconductor process...
Department of Commerce Announces Finalization of CHIPS R&D Award with Rigetti
National Institute of Standards and Technology
WASHINGTON, D.C. — The U.S. Department of Commerce announced today the signing of a final award of up to $100 million to Rigetti under the CHIPS and Science Act. The R&D funded by this award addresses key technical challenges to develop and scale...
Department of Commerce Announces Finalization of CHIPS R&D Award with Quantinuum
National Institute of Standards and Technology
WASHINGTON, D.C. — The U.S. Department of Commerce announced today the signing of a final award of up to $100 million to Quantinuum under the CHIPS and Science Act. The R&D funded by this award addresses critical technology and quantum...
ImageneBio to Participate in H.C. Wainwright 28th Annual Global Investment Conference in New York
GlobeNewswire, Inc.
SAN DIEGO, Sept. 08, 2026 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (Nasdaq: IMA) (“Imagene” or the “Company”) today announced that chief executive officer Kristin Yarema, Ph.D., will participate in a fireside chat at the H.C. Wainwright 28th Annual...
Stand Up for Science Demands Congress Stop Transfer of National Institutes of Health Research Funds to Department of War
EIN Presswire
New petition urges Congress to stop an interagency agreement that would allow health research money to fund War Department’s unspecified priorities.
Lakewood-Amedex Biotherapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference
EIN Presswire
Lakewood-Amedex Biotherapeutics Inc. (NASDAQ:LABT) SARASOTA, FL, UNITED STATES, September 8, 2026 /EINPresswire.com/ -- Lakewood-Amedex Biotherapeutics Inc. (NASDAQ: LABT, the "Company"), a clinical-stage biotechnology company advancing a novel...
Tempest to Present at the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire, Inc.
BRISBANE, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) (“Tempest”), a clinical-stage biotechnology company pioneering the development of advanced in vivo CAR-T therapies for cancer and autoimmune disease,...
Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire, Inc.
MIAMI, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue,...
Calidi Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire, Inc.
SAN DIEGO, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today announces that it will participate...
Sign up for:
DC STEM Digest
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.